Measles virus infection in rhesus macaques: Altered immune responses and comparison of the virulence of six different virus strains

Journal of Infectious Diseases

Volumn 180, Issue 4, 1999, Pages 950-958

  Auwaerter, Paul G ^a,b   Rota, Paul A ^c   Elkins, William R ^d   Adams, Robert J ^b   DeLozier, Tracy ^a,e   Shi, Yaqing ^a   Bellini, William J ^c   Murphy, Brian R ^d   Griffin, Diane E ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 5; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; HOST RESISTANCE; MACACA; MALE; MEASLES; MEASLES VIRUS; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; CERCOPITHECUS AETHIOPS; FEMALE; INTERLEUKIN-1; INTERLEUKIN-2; INTERLEUKIN-6; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTES; MACACA MULATTA; MALE; MEASLES; MEASLES VIRUS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VERO CELLS; VIREMIA; VIRULENCE;

EID: 0033394440     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314993     Document Type: Article

References (52)

1. Beckford AP, Kaschula RO, Stephen C. Factors associated with fatal cases of measles: a retrospective autopsy study. S Afri Med J 1985; 68:858-63.
2. Griffin DE. Immune responses during measles virus infection. Curr Top Microbiol Immunol 1995; 191:117-34.
3. Hussey GD, Goddard EA, Hughes J, et al. The effect of Edmonston-Zagreb and Schwarz measles vaccines on immune responses in infants. J Infect Dis 1996; 173:1320-6.
4. Enders JF, Peebles TC. Propagation in tissue cultures of cytopathic agents from patients with measles. Proc Soc Exp Biol Med. 1954; 86:277-86.
5. Enders JF, Katz SL, Milovanovic MV, et al. Studies of an attenuated measles virus vaccine. I. Development and preparation of the vaccine: technics for assay of effects of vaccination. N Engl J Med 1960; 263:153-9.
6. Katz SL. Immunization with live attenuated measles virus vaccines: five years' experience. Arch ges Virusforsch 1965; 16:222-30.
7. Stokes J Jr, Hilleman MR, Weibel RE, et al. Efficacy of live, attenuated measles-virus vaccine given with human immune globulin: a preliminary report. N Engl J Med 1961; 265:507-13.
8. Schwarz AJF. Preliminary tests of a highly attenuated measles vaccine. Am J Dis Child 1962; 103:216-9.
9. Monafo WJ, Haslam DB, Roberts RL, et al. Disseminated measles infection after vaccination in a child with a congenital immunodeficiency. J Pediatr 1994; 124:273-6.
10. Mawhinney H, Allen IV, Beare JM, et al. Dysgammaglobulinaemia complicated by disseminated measles. Br Med J 1971; 2:380-1.
11. Sergiev PG, Ryazantseva NE, Shroit IG. The dynamics of pathological processes in experimental measles in monkeys. Acta Virol 1960; 4:265-73.
12. Van Binnendijk RS, van der Heijden RWJ, van Amerongen G, et al. Viral replication and development of specific immunity in macaques after infection with different measles virus strains. J Infect Dis 1994; 170:443-8.
13. Potkay S, Ganaway JR, Rogers NG, et al. An epizootic of measles in a colony of rhesus monkeys (Macacca mulatta). Am J Vet Res 1966; 27:331-4.
14. Van Binnendijk RS, van der Heijden RWJ, Osterhaus ADME. Monkeys in measles research. Curr Top Microbiol Immunol 1995; 191:135-48.
15. Albrecht P, Lorenz D, Klutch MJ, et al. Fatal measles infection in marmosets: pathogenesis and prophylaxis. Infect Immun 1980; 27:969-78.
16. Buynak EB, Peck HM, Creamer AA, et al. Differentiation of virulent from avirulent measles strains. Am J Dis Child 1962; 103:291-303.
17. Hall WC, Kovatch RM, Herman PH, et al. Pathology of measles in rhesus monkeys. Vet Pathol 1971; 8:307-19.
18. McChesney MB, Miller CJ, Rota PA, et al. Experimental measles. I. Pathogenesis in the normal and the immunized host. Virology 1997; 133:74-84.
19. Kobune F, Sakata H, Sugiura A, Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J Virol 1990; 64:700-5.
20. Willy ME, Woodward RA, Thornton VB, et al. Management of a measles outbreak among old world nonhuman primates. Lab Anim Sci 1998; 49:42-8.
21. Smaron MF, Saxon E, Wood L, et al. Diagnosis of measles by fluorescent antibody and culture of nasopharyngeal secretions. J Virol Methods 1991; 33:223-9.
22. Rota, JS, Hummel KB, Rota PA, et al. Genetic variability of the glycoprotein genes of current wild-type measles isolates. Virology 1992; 188:135-42.
23. World Health Organization. Standardisation of the nomenclature for describing the genetic characteristics of wild-type measles viruses. Wkly Epidemiol Rec 1998; 73:265-72.
24. Waris M, Ziegler T, Kivivirta M, et al. Rapid detection of respiratory syncytial virus and influenza A virus in cell cultures by immunoperoxidase staining with monoclonal antibodies. J Clin Microbiol 1990; 28:1159-62.
25. Chomezynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
26. Rota PA, Khan AS, Durigon E, et al. Detection of measles virus RNA in urine specimens from vaccine recipients. J Clin Microbiol 1995; 33:2485-8.
27. Rota JS, Wang ZD, Rota PA, et al. Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains. Virus Res 1994; 31:317-30.
28. Albrecht P, Herrmann K, Burns GR. Role of virus strain in conventional and enhanced measles plaque neutralization test. J Virol Methods 1981; 3:251-60.
29. Wesselingh SL, Power C, Glass J, et al. Intracerebral cytokine mRNA expression in AIDS dementia. Ann Neurol 1993; 33:576-82.
30. Tamin A, Rota PA, Wang Z-D, et al. Antigenic analysis of current wild-type and vaccine strains of measles virus. J Infect Dis 1994; 170:795-801.
31. Xu WB, Tamir A, Rota JS, et al. New genetic group of measles virus isolated in the Peoples' Republic of China. Virus Res 1998; 54:147-56.
32. Griffin DE, Cooper SJ, Hirsch RL, et al. Changes in plasma IgE levels during complicated and uncomplicated measles virus infections. J Allergy Clin Immunol 1985; 76:206-13.
33. Griffin DE, Ward BJ. Differential CD4 T cell activation in measles. J Infect Dis 1993; 168:275-81.
34. Anderson JF, Goldberger J. Experimental measles in the monkey: a preliminary note. Public Health Report 1911; 26:847-8.
35. Blake FG, Trask JD Jr. Studies of measles. II. Symptomatology and pathology in monkeys experimentally infected. J Exp Med 1921; 33:413-32.
36. Shaffer MF, Rake G, Stokes J Jr, et al. Studies on measles. II. Experimental disease in man and monkey. J Immunol 1941; 41:241-56.
37. Gordon H, Knighton HT. Experimental measles: the lymphoid tissues of animals inoculated with the virus of human measles. Am J Pathol. 1941; 17:165-76.
38. Enders JF, Peebles TC, McCarthy K, et al. Measles virus: a summary of experiments concerned with isolation, properties, and behavior. Am J Public Health 1957; 47:275-82.
39. Peebles TC, McCarthy K, Enders JF, et al. Behavior of monkeys after inoculation of virus derived from patients with measles and propagated in tissue culture together with observations on spontaneous infections of these animals by an agent exhibiting similar antigenic properties. J Immunol 1957; 78:63-74.
40. Kempe CH, Fulginiti VA. The pathogenesis of measles virus infection. Arch ges Virusforsch 1965; 16:103-28.
41. Kobune F, Takahashi H, Terao K, et al. Nonhuman primate models of measles. Lab Anim Sci 1996; 46:315-20.
42. Takeda M, Kato A, Kobune F, et al. Measles virus attenuation associated with transcriptional impediment and a few amino acid changes in the polymerase and accessory proteins. J Virol 1998; 72:8690-6.
43. Levy BM, Mirkovic RR. An epizootic of measles in a marmoset colony. Lab Anim Sci 1971; 21:33-9.
44. Auwaerter PG, Kaneshima II, McCune JM, et al. Measles virus infection of thymic epithelium in the SCID-hu mouse leads to thymocyte apoptosis. J Virol 1996; 70:3734-40.
45. Wierenga EA, Back B, Snock M, et al. Relative contributions of human types 1 and 2 T-helper cell-derived eosinophilotrophic cytokines to development of eosinophilia. Blood 1993; 82:1471-9.
46. Collins PD, Marleau S, Griffiths-Johnson DA, et al. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995; 182:1169-74.
47. Limaye AP, Ottesen EA, Kumaraswami V, et al. Kinetics of serum and cellular interleukin-5 in posttreatment eosinophilia of patients with lymphatic filariasis. J Infect Dis 1993; 167:1396-400.
48. Kopf M, Brombacher F, Hodgkin PD, et al. IL-5 deficient mice have a developmental detect in CD5 (+) B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 1996; 4:15-24.
49. Cohen AJ, Steigbigel RT. Eosinophilia in patients infected with human immunodeficiency virus. J Infect Dis 1996; 174:615-8.
50. Busse WW, Gern JE, Dick EC. The role of respiratory viruses in asthma. Ciba Found Symp 1997; 206:208-13.
51. Garofalo R, Kimpen JL, Welliver RC, et al. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J Pediatr 1992; 120:28-32.
52. Trigg CJ, Nicholson KG, Wang JH, et al. Bronchial inflammation and the common cold: a comparison of atopic and nonatopic individuals. Clin Exp Allergy 1996; 26:665-76.